Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Clinical trial NCT05264974 · RECRUITING

Trial details

NCT number: NCT05264974
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Soft Tissue Sarcoma

Start date: 2026-03-17
Primary completion: 2026-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.